Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease.
Erika TarascoAnne Sophie von KroghRadomira HrdlickovaThomas R BraschlerTeresa IwaniecPaul N KnöblEriko NakamuraOleg PikovskyStefan FareseOdit GutweinPetr KesslerNina H SchultzCharis von AuerJerzy WindygaKenneth FriedmanIngrid HrachovinovaJames N GeorgeMasanori MatsumotoReinhard SchneppenheimBernhard LämmleJohanna A Kremer HovingaPublished in: Research and practice in thrombosis and haemostasis (2022)
The risk of an acute episode triggered by COVID-19 seems higher than following vaccination in hTTP patients, who can be safely vaccinated against SARS-CoV-2.